Form 4: Humana Director Raquel Bono Boosts Equity Holdings

Humana Inc. Director Raquel C. Bono acquired additional restricted stock units through annual fees and dividend reinvestment, increasing her beneficial ownership.

Summary

• Raquel C. Bono, a Director at Humana Inc., acquired 766 restricted stock units (RSUs) as part of her annual director's fee on January 2, 2026.
• These RSUs represent a contingent right to receive one share of Humana Inc. common stock each and are deferred until her resignation from service as a director.
• Additionally, Bono acquired 34 restricted stock units on December 31, 2025, through the reinvestment of dividend payments on her vested and deferred stock units.
• The dividend reinvestment occurred at a price of $258.8675 per unit.
• Following these transactions, Bono directly owns 397 shares of Humana Common stock.
• She beneficially owns 3,174 restricted stock units from annual fees and 72 restricted stock units from dividend reinvestment.
• All acquisitions are exempt pursuant to Rule 16(b)-3(d)(1) and Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Sentiment

Score: 7

Explanation: The filing indicates a director's continued accumulation of company equity through compensation and reinvestment, which is generally viewed positively as it aligns insider interests with shareholders. There are no negative disclosures.

Positives

• Increased insider ownership by a director, which can signal confidence in the company's future performance.
• Acquisition of shares through annual fees and dividend reinvestment demonstrates a long-term commitment to the company.

Future Outlook

The filing does not provide any forward-looking statements or guidance regarding the company's future performance, focusing solely on insider transaction details.

Industry Context

This routine insider transaction reflects a director's compensation structure and personal investment decisions, which are common across publicly traded companies. It does not provide broader insights into industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: Potentially positive, as increased insider ownership can signal confidence and better alignment of interests.

Next Steps

• The acquired restricted stock units will be converted into Humana Inc. common stock on a 1-for-1 basis upon Raquel C. Bono's resignation from her services as a director.

Key Dates

Recommendation

This Form 4 filing details a routine insider acquisition of restricted stock units by a director as part of compensation and dividend reinvestment. While it indicates continued insider confidence, the transaction size and nature are not significant enough to warrant a change in investment recommendation for Humana Inc. based solely on this filing. It reinforces a 'hold' stance, acknowledging stable corporate governance and compensation practices.

Keywords

Humana Inc., HUM, Raquel C. Bono, Director, Insider Trading, Form 4, Restricted Stock Units, Equity Acquisition, Dividend Reinvestment, Corporate Governance